Abstract
e19065 Background: EGFR mutation positivity (EGFR+) is a known favorable prognostic factor in NSCLC. We sought to understand its significance in the setting of brain metastases (BM) when compared t...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.